Genetic Diversity of Bundibugyo Ebolavirus from Uganda and the Democratic Republic of Congo

Omara, I. E.; Muyingo, S. K.; Balinandi, S.; Nyakarahuka, L.; Kiconco, J.; Kayiwa, J. T.; Mboowa, G.; Jjingo, D.; Lutwama, J. J.

doi:10.1101/2021.10.18.464898

bioRxiv · 10.1101/2021.10.18.464898

Genetic Diversity of Bundibugyo Ebolavirus from Uganda and the Democratic Republic of Congo

Omara, I. E.·Muyingo, S. K.·Balinandi, S.·Nyakarahuka, L.·Kiconco, J.·Kayiwa, J. T.·Mboowa, G.·Jjingo, D.·Lutwama, J. J.

View original source ↗Export metadata ↓

Abstract

BackgroundThe Ebolavirus is one of the deadliest viral pathogens which was first discovered in the year 1976 during two consecutive outbreaks in the Democratic Republic of Congo and Sudan. Six known strains have been documented. The Bundibugyo Ebolavirus in particular first emerged in the year 2007 in Uganda. This outbreak was constituted with 116 human cases and 39 laboratory confirmed deaths. After 5 years, it re-emerged and caused an epidemic for the first time in the Democratic Republic of Congo in the year 2012 as reported by the WHO. Here, 36 human cases with 13 laboratory confirmed deaths were registered. Despite several research studies conducted in the past, there is still scarcity of knowledge available on the genetic diversity of Bundibugyo Ebolavirus. We undertook a research project to provide insights into the unique variants of Bundibugyo Ebolavirus that circulated in the two epidemics that occurred in Uganda and the Democratic Republic of Congo Materials and MethodsThe Bioinformatics approaches used were; Quality Control, Reference Mapping, Variant Calling, Annotation, Multiple Sequence Alignment and Phylogenetic analysis to identify genomic variants as well determine the genetic relatedness between the two epidemics. Overall, we used 41 viral sequences that were retrieved from the publicly available sequence database, which is the National Center for Biotechnology and Information Gen-bank database. ResultsOur analysis identified 14,362 unique genomic variants from the two epidemics. The Uganda isolates had 5,740 unique variants, 75 of which had high impacts on the genomes. These were 51 frameshift, 15 stop gained, 5 stop lost, 2 missense, 1 synonymous and 1 stop lost and splice region. Their effects mainly occurred within the L-gene region at reference positions 17705, 11952, 11930 and 11027. For the DRC genomes, 8,622 variant sites were identified. The variants had a modifier effect on the genome occurring at reference positions, 213, 266 and 439. Examples are C213T, A266G and C439T. Phylogenetic reconstruction identified two separate and unique clusters from the two epidemics. ConclusionOur analysis provided further insights into the genetic diversity of Bundibugyo Ebolavirus from the two epidemics. The Bundibugyo Ebolavirus strain was genetically diverse with multiple variants. Phylogenetic reconstruction identified two unique variants. This signified an independent spillover event from a natural reservoir, rather a continuation from the ancestral outbreak that initiated the resurgence in DRC in the year 2012. Therefore, the two epidemics were not genetically related.

Explore related subjects

genomics Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Omara, I. E., Muyingo, S. K., Balinandi, S., Nyakarahuka, L., Kiconco, J., Kayiwa, J. T., Mboowa, G., Jjingo, D., Lutwama, J. J.. 2021-10-18. Genetic Diversity of Bundibugyo Ebolavirus from Uganda and the Democratic Republic of Congo. https://doi.org/10.1101/2021.10.18.464898

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Sequence and epigenetic characterization of chromosome 21 centromeres in a family with recurrent Trisomy 21

Trisomy 21 (T21) is the most common genetic cause of intellectual disability, yet the molecular mechanisms underlying maternal meiosis I errors--responsible for ~70% of free T21 cases--remain poorly understood. In this preliminary study, we used long-read sequencing and genome assembly to investigate the DNA sequence and epigenetic features of chromosome 21 (chr21) centromeres in a family with recurrent free T21 due to maternal meiosis I errors. The mother, who had two affected and three unaffected children, showed no mosaicism or structural rearrangements. One of her two chr21 centromeres lacked a pronounced centromere dip region (CDR), displaying instead a diffuse hypomethylation pattern (dCDR) with much higher methylated CpG levels (55%) compared to its homologue (36%). This dCDR was transmitted to an unaffected child and the affected proband analyzed, suggesting it was present in one of the maternal chr21 since she was at least 32 years of age. Chr21 dCDRs were not observed in seven young mothers with children with T21 or previously described in the literature in 108 population haplotypes. We hypothesize that dCDRs may weaken kinetochore function, increasing nondisjunction risk, and propose two models linking such epigenetic variation to maternal age-related T21 risk. These findings highlight the value of complete centromere characterization in families with children with T21 and suggest centromere methylation status of chr21 as a potential T21 risk factor for future investigation.

genomics↗

bioRxiv2026

Single-Cell Analytics for Dose Response (SCADR) discriminates PTEN missense variants by lipid and protein phosphatase dysfunction

The proliferation of sequencing efforts has revealed a vast and expanding catalog of single nucleotide gene variants, many associated to, but with unclear roles in disease. Fully charactering variant impacts and linking specific protein dysfunctions to disease are challenging due to the multi-functional nature of many proteins and varying degree of variant effects on these functions. Lagging are sensitive approaches to empirically assess the impact of missense variant-induced single amino acid changes on a wide range of protein functions. To address these issues, we have developed an open-source computational analysis tool called SCADR (Single-Cell Analytics for Dose Response) for simultaneously measuring and comparing impacts of exogenously-expressed variants on multiple signaling pathways using multiplex phospho-antibody spectral flow cytometry in human cell lines. SCADR retains and correlates single-cell measures of signal protein activity states along with expression levels of exogenously-expressed variants, providing rich characterization of multiple protein functions, signaling protein interactions, and enhanced discrimination of variant impacts on different signaling pathways, highlighting each variants unique dysfunction profile. Here, we apply SCADR for analyses of the impact of 6 variants of the tumor-suppressor protein PTEN (P38H, C124S, G129E, Y138L, D268E, 4A) expressed in HEK293 cells on the phosphorylation states of the canonical and noncanonical downstream signaling proteins Akt, S6, CREB, ERK, and p38 detected with fluorophore-conjugated phospho-antibodies, along with an antibody detecting an N-terminal HA tag on PTEN variants allowing measures of dose-response effects of each variants expression on signaling cascades. Results identify variant-specific impacts on downstream signaling cascades.

genomics↗

bioRxiv2026

Microsecond molecular dynamics of SOD1 variants suggest a structural basis for divergent ALS clinical outcomes

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by progressive motor neuron degeneration. Mutations in the SOD1 gene represent the second most common genetic cause of ALS (ALS), and distinct SOD1 missense variants present with markedly different clinical profiles. A4V leads to an aggressive form of the disease (median survival [~]1y), H46R confers a mild, slowly progressive course and I113T exhibits an intermediate phenotype. The molecular basis by which these mutations produce divergent clinical outcomes remains poorly understood. We performed extensive classical molecular dynamics simulations of wild-type SOD1 and the three ALS-associated variants in the apo monomeric state to attempt to investigate the mechanisms behind such phenotypic differences. Structural stability, global compactness, and conformational flexibility, as well as analysis of collective motions between residues and estimation of free energy, were assessed. The H46R, A4V, and I113T variants exhibited distinct dynamic behaviours, highlighting differences in structural stability, local flexibility, and intramolecular interactions. These findings suggest that specific structural regions may contribute differently to protein dysfunction and could represent key elements for understanding the relationship between molecular dynamic properties and the differing clinical severity associated with these variants. Most strikingly, H46R exhibited exceptional structural stability across every analytical level, the lowest global deviation, most attenuated local flexibility, strongest internal dynamic coordination, and the deepest, most confined free energy basins of any system examined. This convergent multi-layered evidence of structural restraint provides a compelling mechanistic basis for the mild and slowly progressive clinical course of H46R ALS, suggesting that enhanced conformational rigidity, rather than bulk destabilisation, is the defining biophysical feature of this variant, and that its pathogenic mechanism operates through a route fundamentally decoupled from the aggregation-driven toxicity that characterises the more aggressive SOD1-ALS mutations.

genomics↗